RxDoctor Payments Data

Timothy Loerke, PA

Physician Assistant · Louisville, KYNPI 1174803050

Payments from drug & device makers

$1,169in general payments, 2019–2025

Across 64 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch Health US, LLC$232
  • Teva Pharmaceuticals USA, Inc.$158
  • Takeda Pharmaceuticals U.S.A., Inc.$158
  • Otsuka America Pharmaceutical, Inc.$144
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$130
  • AbbVie$90
  • plus $258 from 7 others

What the payments were for

  • Food & beverage$1,169100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,169 in reported general payments places this provider in the 70th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$235,843
Medicare patients
327
Services billed
2,416

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine23$64,431
Divalproex Sodium362$20,289
Memantine Hcl123$7,168
Ziprasidone Hcl25$4,318
Mirtazapine192$3,601
Trazodone Hcl296$3,225
Olanzapine35$3,122
Venlafaxine Hcl ErVenlafaxine Hcl167$2,915
Buspirone Hcl115$2,463
Desvenlafaxine Succinate ErDesvenlafaxine Succinate54$2,401
Lorazepam194$2,277
Sertraline Hcl140$2,028
Quetiapine Fumarate71$1,838
Aripiprazole22$1,723
Risperidone82$1,075

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$158$64,43123 claims
Almatica Pharma LLCSertraline Hcl$16$2,028140 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →